Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor.

OBJECTIVES. The aim of this study was to use positron emission tomography (PET)-derived carbon (C)-11 acetate kinetics to determine the effects of dobutamine on oxidative metabolism and its effects on myocardial efficiency in a group of patients with dilated cardiomyopathy. BACKGROUND. Dobutamine is known to improve myocardial function but may do so at the expense of myocardial oxygen consumption, which could be a potential deleterious effect. Carbon-11 acetate kinetics correlate with myocardial oxygen consumption as shown in animal models. Combining these scintigraphic measurements of oxygen consumption with estimates of cardiac work results in a work-metabolic index, which reflects cardiac efficiency. METHODS. Eight patients with nonischemic dilated cardiomyopathy underwent dynamic PET imaging, echocardiography and hemodynamic measurements. Seven of these patients were also studied while receiving dobutamine. Direct measurements of myocardial oxygen consumption using coronary sinus catheterization were obtained with eight of the PET studies to validate C-11 acetate in patients with cardiomyopathy. RESULTS. The mean (+/- SD) C-11 clearance rate significantly increased with dobutamine from 0.105 +/- 0.027 to 0.155 +/- 0.023 min-1 (p = 0.001). Directly measured myocardial oxygen consumption had a linear relation to the mean C-11 clearance rate (r = 0.8, p = 0.018). Dobutamine was noted to significantly reduce systemic vascular resistance as well as the severity of mitral regurgitation. The work-metabolic index determined using hemodynamic variables and PET data increased from 2 +/- 0.7 x 10(4) to 2.6 +/- 0.6 x 10(4) (p = 0.04). Efficiency, estimated by employing the oxygen consumption to k2 relation, also increased from 13 +/- 4.5% to 16.9 +/- 6.4% (p = 0.04). CONCLUSIONS. Despite an increase in myocardial oxygen consumption, dobutamine led to an increase in work-metabolic index in patients with dilated nonischemic cardiomyopathy. Dobutamine reduced systemic vascular resistance and mitral regurgitation, suggesting that in this group of patients, it had important vasodilatory action in addition to its inotropic effects. The use of the C-11 acetate PET for determining myocardial oxygen consumption and estimating efficiency could potentially complement existing clinical measures of ventricular performance and may allow improved and objective evaluation of therapy in patients with heart failure.

This article has been cited by other articles:

				B. J. W. Chow, J. G. Abunassar, K. Ascah, R. deKemp, J. DaSilva, T. Mesana, R. S. Beanlands, and T. D. Ruddy Effects of Mitral Valve Surgery on Myocardial Energetics in Patients With Severe Mitral Regurgitation Circ Cardiovasc Imaging, May 1, 2010; 3(3): 308 - 313. [Abstract] [Full Text] [PDF]

				H. Ukkonen, J. Sundell, and J. Knuuti Effects of CRT on myocardial innervation, perfusion and metabolism Europace, November 1, 2008; 10(suppl_3): iii114 - iii117. [Abstract] [Full Text] [PDF]

				M. M. Henneman, E. E. van der Wall, C. Ypenburg, G. B. Bleeker, N. R. van de Veire, N. A. Marsan, J. Chen, E. V. Garcia, J. J.M. Westenberg, M. J. Schalij, et al. Nuclear Imaging in Cardiac Resynchronization Therapy J. Nucl. Med., December 1, 2007; 48(12): 2001 - 2010. [Abstract] [Full Text] [PDF]

				P. Knaapen, T. Germans, J. Knuuti, W. J. Paulus, P. A. Dijkmans, C. P. Allaart, A. A. Lammertsma, and F. C. Visser Myocardial Energetics and Efficiency: Current Status of the Noninvasive Approach Circulation, February 20, 2007; 115(7): 918 - 927. [Full Text] [PDF]

				H. Tuunanen, E. Engblom, A. Naum, K. Nagren, B. Hesse, K. E. J. Airaksinen, P. Nuutila, P. Iozzo, H. Ukkonen, L. H. Opie, et al. Free Fatty Acid Depletion Acutely Decreases Cardiac Work and Efficiency in Cardiomyopathic Heart Failure Circulation, November 14, 2006; 114(20): 2130 - 2137. [Abstract] [Full Text] [PDF]

				P. Workman, E. O. Aboagye, Y.-L. Chung, J. R. Griffiths, R. Hart, M. O. Leach, R. J. Maxwell, P. M. J. McSheehy, P. M. Price, and J. Zweit Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies. J Natl Cancer Inst, May 3, 2006; 98(9): 580 - 598. [Abstract] [Full Text] [PDF]

				M. J. Welch, J. S. Lewis, J. Kim, T. L. Sharp, C. S. Dence, R. J. Gropler, and P. Herrero Assessment of Myocardial Metabolism in Diabetic Rats Using Small-Animal PET: A Feasibility Study J. Nucl. Med., April 1, 2006; 47(4): 689 - 697. [Abstract] [Full Text] [PDF]

				O. Lindner, J. Sorensen, J. Vogt, E. Fricke, D. Baller, D. Horstkotte, and W. Burchert Cardiac Efficiency and Oxygen Consumption Measured with 11C-Acetate PET After Long-Term Cardiac Resynchronization Therapy J. Nucl. Med., March 1, 2006; 47(3): 378 - 383. [Abstract] [Full Text] [PDF]

				P. Herrero, J. Kim, T. L. Sharp, J. A. Engelbach, J. S. Lewis, R. J. Gropler, and M. J. Welch Assessment of Myocardial Blood Flow Using 15O-Water and 1-11C-Acetate in Rats with Small-Animal PET J. Nucl. Med., March 1, 2006; 47(3): 477 - 485. [Abstract] [Full Text] [PDF]

				J. A. Alhashemi Treatment of cardiogenic shock with levosimendan in combination with {beta}-adrenergic antagonists Br. J. Anaesth., November 1, 2005; 95(5): 648 - 650. [Abstract] [Full Text] [PDF]

				O. Lindner, J. Vogt, D. Baller, A. Kammeier, P. Wielepp, J. Holzinger, B. Lamp, D. Horstkotte, and W. Burchert Global and regional myocardial oxygen consumption and blood flow in severe cardiomyopathy with left bundle branch block Eur J Heart Fail, March 2, 2005; 7(2): 225 - 230. [Abstract] [Full Text] [PDF]

				R. G. Weiss, G. Gerstenblith, and P. A. Bottomley ATP flux through creatine kinase in the normal, stressed, and failing human heart PNAS, January 18, 2005; 102(3): 808 - 813. [Abstract] [Full Text] [PDF]

				O. Lindner, J. Vogt, A. Kammeier, P. Wielepp, J. Holzinger, D. Baller, B. Lamp, B. Hansky, R. Korfer, D. Horstkotte, et al. Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy Eur. Heart J., January 1, 2005; 26(1): 70 - 76. [Abstract] [Full Text] [PDF]

				D Baller, J Vogt, O Lindner, B Lamp, J Holzinger, A Kammeier, P Wielepp, W Burchert, and D Horstkotte Myocardial oxygen consumption and perfusion before and after cardiac resynchronization therapy: experimental observations and clinical implications Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D91 - D97. [Abstract] [Full Text] [PDF]

				L. A. Nikolaidis, D. Trumble, T. Hentosz, A. Doverspike, R. Huerbin, M. A. Mathier, Y.-T. Shen, and R. P. Shannon Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure) Eur J Heart Fail, June 1, 2004; 6(4): 409 - 419. [Abstract] [Full Text] [PDF]

				J. Sundell, E. Engblom, J. Koistinen, A. Ylitalo, A. Naum, K. Q. Stolen, R. Kalliokoski, S. G. Nekolla, K. E. J. Airaksinen, J. J. Bax, et al. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1027 - 1033. [Abstract] [Full Text] [PDF]

				K. Q. Stolen, J. Kemppainen, H. Ukkonen, K. K. Kalliokoski, M. Luotolahti, P. Lehikoinen, H. Hamalainen, T. Salo, K. E. Juhani Airaksinen, P. Nuutila, et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with dilated cardiomyopathy J. Am. Coll. Cardiol., February 5, 2003; 41(3): 460 - 467. [Abstract] [Full Text] [PDF]

				R. J. Gropler Noninvasive measurements of myocardial oxygen consumption--can we do better? J. Am. Coll. Cardiol., February 5, 2003; 41(3): 468 - 470. [Full Text] [PDF]

				H. Ukkonen, R. S.B. Beanlands, I. G. Burwash, R. A. de Kemp, C. Nahmias, E. Fallen, M. R.S. Hill, and A. S.L. Tang Effect of Cardiac Resynchronization on Myocardial Efficiency and Regional Oxidative Metabolism Circulation, January 7, 2003; 107(1): 28 - 31. [Abstract] [Full Text] [PDF]

				I. l S. Kim, H. Izawa, T. Sobue, H. Ishihara, F. Somura, T. Nishizawa, K. Nagata, M. Iwase, and M. Yokota Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1264 - 1268. [Abstract] [Full Text] [PDF]

				L. A Nikolaidis, T. Hentosz, A. Doverspike, R. Huerbin, C. Stolarski, Y.-T. Shen, and R. P Shannon Catecholamine stimulation is associated with impaired myocardial O2 utilization in heart failure Cardiovasc Res, February 1, 2002; 53(2): 392 - 404. [Abstract] [Full Text] [PDF]

				J. van den Hoff, W. Burchert, A.-R. Borner, H. Fricke, G. Kuhnel, G. J. Meyer, D. Otto, E. Weckesser, H.-G. Wolpers, and W. H. Knapp [1-11C]Acetate as a Quantitative Perfusion Tracer in Myocardial PET J. Nucl. Med., August 1, 2001; 42(8): 1174 - 1182. [Abstract] [Full Text] [PDF]

				F. M. Bengel, P. Ueberfuhr, N. Schiepel, S. G. Nekolla, B. Reichart, and M. Schwaiger Myocardial Efficiency and Sympathetic Reinnervation After Orthotopic Heart Transplantation : A Noninvasive Study With Positron Emission Tomography Circulation, April 10, 2001; 103(14): 1881 - 1886. [Abstract] [Full Text] [PDF]

				G. S. Nelson, R. D. Berger, B. J. Fetics, M. Talbot, J. C. Spinelli, J. M. Hare, and D. A. Kass Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block Circulation, December 19, 2000; 102(25): 3053 - 3059. [Abstract] [Full Text] [PDF]

				R. S. B. Beanlands, C. Nahmias, E. Gordon, G. Coates, R. deKemp, G. Firnau, and E. Fallen The Effects of {beta}1-Blockade on Oxidative Metabolism and the Metabolic Cost of Ventricular Work in Patients With Left Ventricular Dysfunction : A Double-Blind, Placebo-Controlled, Positron-Emission Tomography Study Circulation, October 24, 2000; 102(17): 2070 - 2075. [Abstract] [Full Text] [PDF]

				F. M. Bengel, S. G. Nekolla, T. Ibrahim, C. Weniger, S. I. Ziegler, and M. Schwaiger Effect of Thyroid Hormones on Cardiac Function, Geometry, and Oxidative Metabolism Assessed Noninvasively by Positron Emission Tomography and Magnetic Resonance Imaging J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1822 - 1827. [Abstract] [Full Text]

				A. F. M. van den Heuvel, D. J. van Veldhuisen, E. E. van der Wall, P. K. Blanksma, H.-M. J. Siebelink, W. M. Vaalburg, W. H. van Gilst, and H. J. G. M. Crijns Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., January 1, 2000; 35(1): 19 - 28. [Abstract] [Full Text] [PDF]

				H. Laine, C. Katoh, M. Luotolahti, H. Yki-Jarvinen, I. Kantola, A. Jula, T. O. Takala, U. Ruotsalainen, H. Iida, M. Haaparanta, et al. Myocardial Oxygen Consumption Is Unchanged but Efficiency Is Reduced in Patients With Essential Hypertension and Left Ventricular Hypertrophy Circulation, December 14, 1999; 100(24): 2425 - 2430. [Abstract] [Full Text] [PDF]

				T. O. Takala, P. Nuutila, C. Katoh, M. Luotolahti, J. Bergman, M. Maki, V. Oikonen, U. Ruotsalainen, T. Gronroos, M. Haaparanta, et al. Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E585 - E590. [Abstract] [Full Text] [PDF]

				H. H. Lee, V. G. Davila-Roman, P. A. Ludbrook, M. Courtois, J. F. Walsh, D. A. Delano, P. J. Rubin, and R. J. Gropler Dependency of Contractile Reserve on Myocardial Blood Flow : Implications for the Assessment of Myocardial Viability With Dobutamine Stress Echocardiography Circulation, November 4, 1997; 96(9): 2884 - 2891. [Abstract] [Full Text]

				M. Schwaiger and I. Kosa Cardiovascular Positron Emission Tomography: A Possible Tool for Assessment of New Pharmaceuticals Drug Information Journal, July 1, 1997; 31(3): 1029 - 1034. [Abstract] [PDF]